A Study of HS-20094 in T2DM Participants
NCT06118008
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes
Interventions
DRUG:
HS-20094 5mg
DRUG:
HS-20094 10mg
DRUG:
HS-20094 15mg
DRUG:
HS-20094 20mg
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.